Literature DB >> 10078531

Regulation of calcium signalling in T lymphocytes by the second messenger cyclic ADP-ribose.

A H Guse1, C P da Silva, I Berg, A L Skapenko, K Weber, P Heyer, M Hohenegger, G A Ashamu, H Schulze-Koops, B V Potter, G W Mayr.   

Abstract

Cyclic ADP-ribose (cADPR) is a natural compound that mobilizes calcium ions in several eukaryotic cells. Although it can lead to the release of calcium ions in T lymphocytes, it has not been firmly established as a second messenger in these cells. Here, using high-performance liquid chromatography analysis, we show that stimulation of the T-cell receptor/CD3 (TCR/CD3) complex results in activation of a soluble ADP-ribosyl cyclase and a sustained increase in intracellular levels of cADPR. There is a causal relation between increased cADPR concentrations, sustained calcium signalling and activation of T cells, as shown by inhibition of TCR/CD3-stimulated calcium signalling, cell proliferation and expression of the early- and late-activation markers CD25 and HLA-DR by using cADPR antagonists. The molecular target for cADPR, the type-3 ryanodine receptor/calcium channel, is expressed in T cells. Increased cADPR significantly and specifically stimulates the apparent association of [3H]ryanodine with the type-3 ryanodine receptor, indicating a direct modulatory effect of cADPR on channel opening. Thus we show the presence, causal relation and biological significance of the major constituents of the cADPR/calcium-signalling pathway in human T cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10078531     DOI: 10.1038/18024

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  88 in total

1.  Mobilization of Ca2+ by cyclic ADP-ribose from the endoplasmic reticulum of cauliflower florets.

Authors:  L Navazio; P Mariani; D Sanders
Journal:  Plant Physiol       Date:  2001-04       Impact factor: 8.340

Review 2.  Calcium channels in lymphocytes.

Authors:  G Grafton; L Thwaite
Journal:  Immunology       Date:  2001-10       Impact factor: 7.397

3.  Kinetic competence of the cADP-ribose-CD38 complex as an intermediate in the CD38/NAD+ glycohydrolase-catalysed reactions: implication for CD38 signalling.

Authors:  C Cakir-Kiefer; H Muller-Steffner; N Oppenheimer; F Schuber
Journal:  Biochem J       Date:  2001-09-01       Impact factor: 3.857

4.  Site-directed removal of N-glycosylation sites in BST-1/CD157: effects on molecular and functional heterogeneity.

Authors:  S Yamamoto-Katayama; A Sato; M Ariyoshi; M Suyama; K Ishihara; T Hirano; H Nakamura; K Morikawa; H Jingami
Journal:  Biochem J       Date:  2001-07-15       Impact factor: 3.857

Review 5.  What is the evidence for the role of TRP channels in inflammatory and immune cells?

Authors:  A Parenti; F De Logu; P Geppetti; S Benemei
Journal:  Br J Pharmacol       Date:  2016-02-18       Impact factor: 8.739

6.  Evidence that the cADPR signalling pathway controls calcium-mediated microneme secretion in Toxoplasma gondii.

Authors:  Eduardo N Chini; Kisaburo Nagamune; Dawn M Wetzel; L David Sibley
Journal:  Biochem J       Date:  2005-07-15       Impact factor: 3.857

7.  Cellular effects and metabolic stability of N1-cyclic inosine diphosphoribose and its derivatives.

Authors:  T Kirchberger; G Wagner; J Xu; C Cordiglieri; P Wang; A Gasser; R Fliegert; S Bruhn; A Flügel; F E Lund; L-H Zhang; B V L Potter; A H Guse
Journal:  Br J Pharmacol       Date:  2006-09-11       Impact factor: 8.739

Review 8.  Signaling properties of CD38 in the mouse immune system: enzyme-dependent and -independent roles in immunity.

Authors:  Frances E Lund
Journal:  Mol Med       Date:  2006 Nov-Dec       Impact factor: 6.354

Review 9.  CD38 as a regulator of cellular NAD: a novel potential pharmacological target for metabolic conditions.

Authors:  Eduardo Nunes Chini
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

10.  Dual role of CD38 in microglial activation and activation-induced cell death.

Authors:  Lior Mayo; Jasmine Jacob-Hirsch; Ninette Amariglio; Gideon Rechavi; Marie-Jo Moutin; Frances E Lund; Reuven Stein
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.